Jing Yuan

20.7k total citations · 3 hit papers
122 papers, 4.1k citations indexed

About

Jing Yuan is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Jing Yuan has authored 122 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Epidemiology, 49 papers in Infectious Diseases and 18 papers in Molecular Biology. Recurrent topics in Jing Yuan's work include SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (17 papers) and Hepatitis B Virus Studies (16 papers). Jing Yuan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (17 papers) and Hepatitis B Virus Studies (16 papers). Jing Yuan collaborates with scholars based in China, United States and Hong Kong. Jing Yuan's co-authors include Zheng Zhang, Fuxiang Wang, Mingfeng Liao, Yang Liu, Shuye Zhang, Yanling Wen, Gang Xu, Lin Cheng, Juanjuan Zhao and Lei Liu and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jing Yuan

108 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

2020 1.6k citations Yang Liu, Jing Yuan et al. profile →
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020

2020 506 citations Xuejiao Liao, Jing Yuan et al. profile →
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights

2020 431 citations Jing Yuan, Lei Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jing Yuan China	22	2.2k	869	759	704	626	122	4.1k
Chengliang Zhu China	29	1.9k 0.9×	834 1.0×	736 1.0×	648 0.9×	739 1.2×	88	3.7k
Fang Li China	30	1.6k 0.7×	377 0.4×	940 1.2×	459 0.7×	686 1.1×	176	4.5k
Matthew Zirui Tay Singapore	10	2.1k 0.9×	937 1.1×	759 1.0×	588 0.8×	595 1.0×	17	3.7k
Wei Hou China	32	1.9k 0.9×	366 0.4×	859 1.1×	623 0.9×	887 1.4×	127	6.2k
Qiwei Zhang China	35	2.4k 1.1×	549 0.6×	1.5k 2.0×	1.3k 1.8×	739 1.2×	203	5.9k
Yijin Wang China	17	4.5k 2.0×	2.4k 2.7×	760 1.0×	450 0.6×	725 1.2×	52	6.7k
Jin‐Wen Song China	17	4.5k 2.0×	2.4k 2.7×	896 1.2×	631 0.9×	681 1.1×	63	6.9k

Countries citing papers authored by Jing Yuan

Since Specialization

Citations

This map shows the geographic impact of Jing Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Yuan more than expected).

Fields of papers citing papers by Jing Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Yuan. The network helps show where Jing Yuan may publish in the future.

Co-authorship network of co-authors of Jing Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Yuan. A scholar is included among the top collaborators of Jing Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Yuan. Jing Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xue, Chunyuan, Yimeng Du, Jigui Shan, et al.. (2025). TIMM10 enhances MAVS mediated innate immune response against influenza A virus infection. Colloids and Surfaces A Physicochemical and Engineering Aspects. 718. 136900–136900.

Wang, Tianying, et al.. (2025). Study on the friction and wear characteristics of NiCoCrAlYTa-Cr2O3-Cu-Mo composite coating and GH4214 under different temperature test conditions. Tribology International. 211. 110851–110851.

Zhao, Sheng, Mengyuan Liu, Fei Yu, et al.. (2025). Effectiveness of an AI-enhanced management system for coronary heart disease (AIM-CHD): rationale and design of a single-centre, open-label, randomised, parallel-controlled trial. BMJ Open. 15(9). e105597–e105597.

Ran, Ran, Hongtao Li, Hongtao Li, et al.. (2025). Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial. International Journal of Cancer. 156(11). 2178–2187.

Zhao, Enyue, Chan Li, Jing Yuan, et al.. (2024). The molecular mechanism of electrical stimulation on enhancing the foaming properties of egg white liquid. Food Hydrocolloids. 162. 111010–111010. 4 indexed citations

Xue, Yueguang, Shilin Li, Jie Mei, et al.. (2024). DEPDC1 is a potential therapeutic target in lung adenocarcinoma. Nano Today. 56. 102249–102249. 1 indexed citations

Guo, Xiaohui, Cheng Zhang, Tao Ning, et al.. (2024). Prusogliptin ( DBPR108 ) monotherapy in treatment‐naïve patients with type 2 diabetes: A randomized, double‐blind, active and placebo‐controlled, phase 3 study. Diabetes Obesity and Metabolism. 26(4). 1321–1332. 2 indexed citations

Yu, Lei, Congying Wang, Xiaoyun Li, et al.. (2023). Clinical characteristics of abruptly increased paediatric patients with Omicron BF.7 or BA.5.2 in Beijing. Virology Journal. 20(1). 209–209. 5 indexed citations

Wu, Yushan, et al.. (2023). Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China. HIV Medicine. 25(5). 529–539. 3 indexed citations

10.

Qi, Furong, Gang Xu, Xuejiao Liao, et al.. (2021). ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers. Cell Discovery. 7(1). 56–56. 6 indexed citations

11.

Xu, Wenxiong, Lu Wang, Hongbo Gao, et al.. (2021). Efficacy and safety of combination treatment of double plasma molecular adsorption system and low volume plasma exchange for patients with hepatitis B virus related acute-on-chronic liver failure: a multicentre randomised controlled clinical trial. BMJ Open. 11(12). e047690–e047690. 9 indexed citations

12.

Zu, Wenhong, Yang Liu, Junhua Li, et al.. (2021). Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis. Virulence. 12(1). 1209–1226. 20 indexed citations

13.

Wu, Lina, Yongyu Mei, Zhihua Liu, et al.. (2021). Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol. BMJ Open. 11(10). e049104–e049104. 1 indexed citations

14.

Zhang, Peiyan, Zhao Cai, Weibo Wu, et al.. (2020). The novel coronavirus (COVID-19) pneumonia with negative detection of viral ribonucleic acid from nasopharyngeal swabs: a case report. BMC Infectious Diseases. 20(1). 12 indexed citations

15.

Yuan, Jing, Shanglong Kou, Yanhua Liang, et al.. (2020). <p>Immunological Evaluation on Potential Treatment Window for Hospitalized COVID-19 Patients</p>. Journal of Inflammation Research. Volume 13. 985–993. 4 indexed citations

16.

Yu, Zhixin, Min Deng, Yi Chen, et al.. (2019). A system dynamics modelling simulation based on a cohort of hepatitis B epidemic research in east China community. Epidemiology and Infection. 147. e86–e86. 4 indexed citations

17.

Liu, Xi, Zheng Yang, Jing Yuan, et al.. (2017). Early Antibody Response Contributes to the Virus Eradication and Clinical Recovery of H7N9 Influenza Infection.. PubMed. 47(5). 592–599. 4 indexed citations

18.

Liu, Yingxia, et al.. (2013). The clinical and laboratory features of severe foot, and mouth disease, Shenzhen city and 1 year follow-up report. 27(6). 406–409. 1 indexed citations

19.

Yuan, Jing. (2007). Comparison of adjuvant for porcine circovirus type 2 inactivated vaccines. Zhongguo yufang shouyi xuebao. 1 indexed citations

20.

Li, Jing, Betty Tang, Joseph Eckman, et al.. (2007). Antitumor efficacy of LBY135, an anti-DR5 monoclonal antibody, alone or in combination with chemotherapy in human colon tumor cell lines and xenografts. Cancer Research. 67. 4874–4874. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengliang Zhu Breakdown of academic impact, for papers by Fang Li Breakdown of academic impact, for papers by Matthew Zirui Tay Breakdown of academic impact, for papers by Wei Hou Breakdown of academic impact, for papers by Qiwei Zhang Breakdown of academic impact, for papers by Yijin Wang Breakdown of academic impact, for papers by Jin‐Wen Song